AI
AIMD.US Ainos Inc
- Market cap
- USD 10.7M
- P/E
- -
- P/B
- 2.80x
- ROE
- -429.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is AIMD.US undervalued?
Graham numberThe Graham number of Ainos Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ainos Inc fundamental analysis
No fundamental analysis for Ainos Inc yet.
Ainos Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ainos Inc
Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develo…
Full company profileAinos Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ainos Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 251K | 77.7K | 11.7K | 16.6K | 595K | 3.52M | 122K | 20.7K | 124K | 626.00 |
| Gross Profit | -26.0K | 191K | 12.8K | 2.96K | 5.29K | 410K | 1.41M | -254K | -31.9K | -4.68M | -4.72M |
| Operating Income | -667K | -580K | -1.33M | -1.58M | -1.44M | -3.87M | -14.0M | -13.2M | -13.8M | -14.0M | -13.4M |
| EBITDA | -641K | -540K | -1.28M | -1.56M | -1.43M | -1.83M | -9.12M | -8.75M | -9.44M | -9.28M | -8.64M |
| Net Income | -670K | -617K | -1.34M | -1.58M | -1.45M | -3.89M | -14.0M | -13.8M | -14.9M | -14.8M | -14.1M |
| EPS | -0.50 | -0.41 | -0.56 | -0.74 | -2.67 | -2.57 | -5.14 | -3.36 | -1.56 | -3.46 | -1.92 |
| Balance Sheet | |||||||||||
| Total Assets | 463K | 2.29M | 1.46M | 597K | 260K | 40.8M | 37.1M | 31.8M | 28.8M | 20.9M | 19.6M |
| Total Liabilities | 1.27M | 1.82M | 734K | 753K | 1.10M | 30.6M | 2.48M | 7.39M | 13.3M | 13.3M | 16.3M |
| Shareholders' Equity | -810K | 471K | 730K | -157K | -838K | 10.2M | 34.6M | 24.4M | 15.5M | 7.56M | 3.28M |
| Cash & Short-term Investments | 134K | 1.98M | 1.28M | 409K | 22.2K | 1.75M | 1.85M | 1.89M | 3.89M | 417K | 1.42M |
| Total Debt | 791K | 886K | 513K | 445K | 953K | 3.62M | 1.27M | 5.96M | 12.0M | 11.0M | 13.8M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -521K | -543K | -1.01M | -909K | -500K | -1.25M | -3.04M | -4.69M | -5.81M | -4.61M | -4.86M |
| Capital Expenditure | 148K | 49.1K | 7.28K | 13.1K | 7.24K | 144K | 634K | 93.0K | 21.3K | 34.6K | 28.6K |
| Free Cash Flow | -669K | -592K | -1.02M | -923K | -507K | -1.39M | -3.67M | -4.79M | -5.83M | -4.65M | -4.89M |
| Ratios | |||||||||||
| ROE | - | -131.1% | -183.4% | - | - | -38.1% | -40.4% | -56.3% | -95.8% | -195.3% | -429.6% |
| ROA | -144.8% | -26.9% | -91.5% | -265.2% | -557.3% | -9.5% | -37.7% | -43.2% | -51.6% | -70.8% | -72.1% |
| Net Profit Margin | - | -246.0% | -1,722.3% | -13,487.2% | -8,758.2% | -654.0% | -398.0% | -11,277.0% | -71,702.3% | -11,897.0% | -2,253,843.8% |
| Debt to Equity | - | 1.88x | 0.70x | - | - | 0.36x | 0.04x | 0.24x | 0.77x | 1.45x | 4.21x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ainos Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 48.3K | 0.01 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | USD 34.3K | 0.01 | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Jun 30, 2025.
Who owns Ainos Inc
- Insiders 60.21%
- Institutions 2.00%
- Public & others 37.79%
- Shares outstanding 8.72M
- Free float 2.40M
Top funds holding AIMD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index | 23.1K | 0.31% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 19.8K | 0.27% | 0.00% | Sep 2026 |
Top institutions holding AIMD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Geode Capital Management, LLC | 44.1K | 0.60% | -16.93% | Jun 2026 |
| HRT FINANCIAL LLC | 32.0K | 0.43% | 0.00% | Jun 2026 |
| Keystone Financial Group Inc | 25.6K | 0.35% | +75.60% | Jun 2026 |
| Vanguard Capital Management, LLC | 16.0K | 0.22% | +72.65% | Jun 2026 |
| Mariner Wealth Advisors LLC | 15.8K | 0.21% | -48.70% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 14.2K | 0.19% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 11.5K | 0.16% | 0.00% | Jun 2026 |
| UBS Group AG | 4.59K | 0.06% | +229,500.00% | Jun 2026 |
| Tower Research Capital LLC | 3.16K | 0.04% | -28.91% | Jun 2026 |
| BlackRock Inc | 3.07K | 0.04% | 0.00% | Jun 2026 |
| Steward Partners Investment Advisory, LLC | 1.21K | 0.02% | 0.00% | Jun 2026 |
| Citigroup Inc | 177.00 | 0.00% | -64.67% | Jun 2026 |
| Caitong International Asset Management Co., Limited. | 93.00 | 0.00% | 0.00% | Jun 2026 |
Ainos Inc company profile
- Company name
- Ainos Inc
- Ticker
- AIMD.US
- Exchange
- USA Stocks
- Listed since
- Nov 4, 2013
- Sector
- Technology
- Industry
- Health Care Equipment & Supplies
- Employees
- 41
- Fiscal year end
- December
- Address
- 3050 Post Oak Boulevard, Houston, TX, United States, 77056
- Phone
- 281 898 6586
- Website
- ainos.com
About Ainos Inc
Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
Ainos Inc management
3- Mr. Chun-Hsien TsaiCEO, President & Chairman of the Board · born 1970
- Mr. Hsin-Liang LeeChief Financial Officer · born 1971
- Mr. Chih-Heng LuDirector of Corporate Developoment · born 1980